|
Ranbaxy
charts out multi-pronged strategy to boost NDDR
RANBAXY Laboratories while undertaking the planned expansion
of the R&D facility is looking at employing all available tools
to invigorate its new drug discovery research (NDDR) kitty.
Natco
Pharma launches generic imatinib
NATCO Pharma Ltd here has launched an anti-cancer drug under
the brand Veenat (Imatinib 100 mg capsules).
Indoco’s
Verna factory gets UK-MCA nod
The Verna-Goa based solid dosage facility of Indoco Remedies
Limited has received the UK-MCA certification.
Micro
Labs all set to enter regulated markets
The Rs 20 crore formulations plant of the Bangalore based pharma
major Micro Labs which is in final stages of completion, is expecting
UKMCA approval as part of its first initiative to foray into the
regulated markets.
Q3
Results
|